Anticuerpos monoclonales como tratamiento para la esclerosis múltiple: efectividad, seguridad y perspectivas futuras

Abstract

TITLE: Monoclonal Antibodies as a Treatment for Multiple Sclerosis: Efficacy, Safety, and Future Prospects. The treatment of multiple sclerosis may include lifestyle changes and/or the administration of drugs, depending on the severity and clinical manifestations presented by the patient. OBJECTIVE: To analyze the efficacy and safety associated with the use of monoclonal antibodies as a treatment for multiple sclerosis. METHODOLOGY: This research consists of a descriptive literature review with a qualitative approach, supported by 55 publications obtained from scientific databases such as Scopus, Lilacs, Redalyc, PubMed, Web of Science, and SciELO. CONCLUSION: Multiple sclerosis has no cure, but the emergence of monoclonal antibodies represents a reliable alternative to reduce the severity of symptoms, control the progression of disability, prevent new relapses, and improve the quality of life of patients.